Last updated on April 2018

HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors


Brief description of study

The purpose of this study is to determine whether Doxil (liposomal doxorubicin) given prior to MR-HIFU Hyperthermia is safe for the treatment of pediatric and young adult patients with recurrent and refractory solid tumors.

Clinical Study Identifier: NCT02557854

Contact Investigators or Research Sites near you

Start Over

Theodore Laetsch, MD

UT Southwestern Medical Center/Children's Medical Center
Dallas, TX United States
  Connect »